Organovo Appoints New Board Member
20 févr. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Aether and Procter & Gamble Begin 3D Printing and AI Development Project
19 févr. 2019 10h53 HE
|
Aether
SAN FRANCISCO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aether, the pioneer of AI enhanced 3D printing and bioprinting, today announced the commencement of a two year joint development agreement with...
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results
07 févr. 2019 16h05 HE
|
Organovo, Inc.
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Submit first IND in calendar 2020 SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc....
3Scan Hosts San Francisco Biotech Showcase with Prellis Biologics and Announces Real Human Tissue Structures for R&D Bioprinting with the Holograph-X
07 janv. 2019 19h22 HE
|
3Scan
San Francisco, Jan. 07, 2019 (GLOBE NEWSWIRE) -- 3Scan, the world’s leading 3D tissue imaging company and creators of the largest high-resolution vascular tissue data sets in the world, is hosting a...
3Scan Hosts San Francisco Biotech Showcase with Prellis Biologics and Announces Real Human Tissue Structures for R&D Bioprinting with the Holograph-X
07 janv. 2019 19h11 HE
|
3Scan
San Francisco, Jan. 07, 2019 (GLOBE NEWSWIRE) -- 3Scan, the world’s leading 3D tissue imaging company and creators of the largest high-resolution vascular tissue data sets in the world, is hosting a...
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
23 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29 mai 2018 08h02 HE
|
BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University
05 févr. 2018 08h01 HE
|
BIOLIFE4D Corporation
CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a...
BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M
01 févr. 2018 06h00 HE
|
BIOLIFE4D Corporation
CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a...